Webinar Series Introduction
Welcome to the Stroke Reduction with LAA Closure CME-accredited webinar series, which offers on-demand archives of past live webinars and announces upcoming activities. The activities highlight the experiences and insights of world-renowned multidisciplinary faculty experts on stroke risk reduction with LAA Closure and on optimal clinical decision-making strategies for improved patient care.
Upcoming Live Webinar |
Stroke Risk Reduction with LAA Closure: Individualizing Care Through SIMPLAAFY Insights on Post-Implant Therapy and Shared Decision-Making
Tuesday, November 10, 2026 • 7:00 to 8:00 PM Eastern Standard Time
Activity Description
The CME-accredited webinar opens with a presentation on Shared Decision and Patient Perspective, followed by a presentation on SIMPLAAFY, a late-breaking clinical trial presented at TCT 2026. This large, randomized, multicenter study examines whether lower-intensity drug regimens after left atrial appendage closure reduce stroke and bleeding risks compared with standard dual antiplatelet therapy (DAPT). An extended, moderated panel discussion will explore the trial results and their impact on practice, including DAPT analysis, post-implant drug strategies, and shared decision-making. Faculty will answer attendee questions during the final panel and Q&A session.
On-Demand Library |
Stroke Risk Reduction with LAA Closure: A Meta-Analysis of Randomized Trials
Activity Description
This CME-accredited on-demand webinar features a multidisciplinary panel of experts who thoroughly review an updated meta-analysis of randomized controlled trials comparing Left Atrial Appendage Closure (LAAC) with oral anticoagulation in patients with atrial fibrillation. The discussion focuses on efficacy and safety, including bleeding risks such as clinically relevant non-major bleeding, and on stroke characterization data. The faculty evaluate how these results can inform personalized, patient-centered decisions by weighing stroke and bleeding risks.
Stroke Risk Reduction with LAA Closure: Clinical Indications and Patient Considerations
Activity Description
This CME-accredited on-demand webinar features a multidisciplinary faculty of experts who discuss the role of WATCHMAN therapy in reducing stroke risk. It offers a comprehensive review of recent clinical data, with a particular focus on the CHAMPION-AF trial presented at the ACC Scientific Sessions 2026. The panel evaluates how new data influence patient care and treatment choices and explores patient selection and clinical decision-making strategies through case reviews.
CHAMPION-AF Clinical Trial Results and Impact on Practice
Activity Description
The CME-accredited on-demand webinars include archives of three geo-targeted live broadcasts reviewing the CHAMPION-AF clinical trial, which was released at the ACC Scientific Sessions 2026 and published simultaneously in The New England Journal of Medicine. Each session features the late-breaking clinical trial presentation from the prospective, randomized, multi-center global study led by Principal Investigator Dr. Shephal Doshi. Additionally, each includes a unique moderator and panelists from multiple disciplines and regions of practice, who analyze the global impact of the results on healthcare systems in different regions and assess future directions.